Interestingly, CD169 expression in immune cells is induced by type I IFN (28, 33), and it has been observed to be upregulated in monocytes in autoimmune diseases with a type I IFN signature, such as systemic lupus erythematosus and systemic sclerosis (42). Here, SIGLEC1 is linked to systemic lupus erythematosus.